Grantham, Mayo, Van Otterloo & Co. LLC
- SEC CIK
- 0001352662
- Latest filing
- Aug 13, 2026
DGX holding history
Quest Diagnostics Inc in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DGX overviewAll 13F holders of DGXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,888,207
- Value
- $400.2M
- % of portfolio
- 0.9%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,888,207 | $400.2M | 0.9% | +5,183+0.3% | Added | Holders |
| Q1 2026 | 1,883,024 | $369.0M | 0.9% | +66,964+3.7% | Added | Holders |
| Q4 2025 | 1,816,060 | $315.1M | 0.8% | +69,660+4.0% | Added | Holders |
| Q3 2025 | 1,746,400 | $332.8M | 0.9% | −1,552−0.1% | Reduced | Holders |
| Q2 2025 | 1,747,952 | $314.0M | 0.9% | −258,593−12.9% | Reduced | Holders |
| Q1 2025 | 2,006,545 | $339.5M | 1.1% | −262,445−11.6% | Reduced | Holders |
| Q4 2024 | 2,268,990 | $342.3M | 1.1% | +26,214+1.2% | Added | Holders |
| Q3 2024 | 2,242,776 | $348.2M | 1.1% | +114,055+5.4% | Added | Holders |
| Q2 2024 | 2,128,721 | $291.4M | 1.0% | +85,466+4.2% | Added | Holders |
| Q1 2024 | 2,043,255 | $272.0M | 1.0% | +338,108+19.8% | Added | Holders |
| Q4 2023 | 1,705,147 | $235.1M | 1.0% | +68,740+4.2% | Added | Holders |
| Q3 2023 | 1,636,407 | $199.4M | 0.9% | +38,041+2.4% | Added | Holders |
| Q2 2023 | 1,598,366 | $224.7M | 1.0% | +100,333+6.7% | Added | Holders |
| Q1 2023 | 1,498,033 | $211.9M | 1.1% | +14,800+1.0% | Added | Holders |
| Q4 2022 | 1,483,233 | $232.0M | 1.2% | −215,400−12.7% | Reduced | Holders |
| Q3 2022 | 1,698,633 | $208.4M | 1.2% | −36,962−2.1% | Reduced | Holders |
| Q2 2022 | 1,735,595 | $230.8M | 1.3% | −34,160−1.9% | Reduced | Holders |
| Q1 2022 | 1,769,755 | $242.2M | 1.2% | −9,169−0.5% | Reduced | Holders |
| Q4 2021 | 1,778,924 | $307.8M | 1.5% | +5,569+0.3% | Added | Holders |
| Q3 2021 | 1,773,355 | $257.7M | 1.3% | +57,258+3.3% | Added | Holders |
| Q2 2021 | 1,716,097 | $226.5M | 1.1% | +176,742+11.5% | Added | Holders |
| Q1 2021 | 1,539,355 | $197.6M | 1.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.